A
ADPT icon

AJOVista’s Adaptive Biotechnologies ADPT Stock Holding History

AJOVista’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$288K Buy
+56,270
New +$245K 1.23% 11

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AJOVista's ADPT Position: Q3 2024 in Review

AJOVista opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2024: 56,270 shares worth $288K. The stake represents 1.23% of the portfolio and ranks #11 among its holdings.

187 funds tracked by Wall St. Rank hold ADPT as of Q3 2024.

  • AJOVista held 56,270 shares of Adaptive Biotechnologies worth $288K as of Q3 2024.
  • Adaptive Biotechnologies was a new AJOVista position in Q3 2024.
  • Adaptive Biotechnologies made up 1.23% of AJOVista's portfolio in Q3 2024, its #11 holding.
  • 187 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.